© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
300501 |
As an accredited 3-Bromo-2-Fluoroaniline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3-Bromo-2-Fluoroaniline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
People who work in organic synthesis often search for molecules that offer flexibility during the design phase of a project. 3-Bromo-2-Fluoroaniline answers that need in a unique way. This compound, with its bromo group at the 3-position and fluorine at the 2-position on an aniline ring, isn’t just part of a list in a manufacturer’s catalog: it shows up as a reliable stepping stone in countless research and production routes. The push for more precise ways to build pharmaceuticals, agrochemicals, and specialty dyes keeps nudging chemists toward starting materials like this. Through my own work with academic researchers and folks in pharmaceutical development, I’ve seen how the right substitution pattern on a simple aromatic ring changes everything—yields, selectivity, and downstream costs all pivot on these details.
3-Bromo-2-Fluoroaniline rarely comes up in household conversation, yet its purity levels and defined substitution pattern matter in places far from the chemistry bench. Routine specs set a benchmark—over 98% purity sets the standard for most synthetic needs. The smallest contamination can derail weeks of work, especially in drug discovery labs. I remember a colleague whose early-stage screen failed repeatedly before determining that the problem traced back to an impurity in the amine donor. The lesson stuck, both for him and the wider team: verifying the quality of each building block, including tricky ones like halogenated anilines, pays off in both time and confidence downstream.
Aniline rings, once you start adding halogens, can pivot from being basic reagents into prized building blocks. Attaching a bromine at the 3-position creates a site ripe for cross-coupling, letting chemists tap into trusted protocols—Suzuki, Buchwald-Hartwig, and others—for rapid structure diversification. With fluorine at the 2-position, things change once again: the electron-drawing nature of fluorine modifies reactivity and pushes selectivity toward certain reaction types. In effect, having the fluoro group next to the amine limits side reactions and allows for some surprising twists in where reactions “feel” the most chemical action. I've listened to chemists celebrate when they replace a hydrogen with fluorine and notice better yields, higher selectivity, and outcomes that simply work better in downstream trials.
The thing about 3-Bromo-2-Fluoroaniline is, its utility isn’t boxed into a single industry. Drug developers tap it when they chase novelty—the twin forces of regulatory hurdles and new disease targets make aromatic amine scaffolds with unique substitution patterns a focus of attention. Fluorinated motifs alter metabolic stability and can help molecules escape the body’s rapid clearance mechanisms, conferring drug candidates with longer activity in vivo. Meanwhile, the bromine serves as a functional “handle” for further expansions—chemist jargon for “site of further reaction.” In my experience with crop science clients, these same motifs show up when researchers try to produce next-generation herbicides or fungicides that dodge pests’ evolved resistance. Even pigment specialists look for ways to introduce subtle tweaks to color profiles, so tweaks in ring substituents help fine-tune light absorption in advanced dyes.
People often ask what sets 3-Bromo-2-Fluoroaniline apart from other anilines. Start with the abovementioned group effects—in other isomers or unhalogenated anilines, electron density distributes differently around the ring, dictating very different chemistry. Swap a bromine for a chlorine or shuffle the fluoro position, and suddenly you have chemicals with different boiling points, different reactivity with palladium catalysts, and altered environmental profiles. A matter of one atom really makes all the difference. Not every project calls for this specific molecule, but once you need its unique mix of properties, nearly nothing else will do. Over years in consulting settings, I’ve heard researchers lament supply chain run-ins: “We tried the 4-bromo version, but it wouldn’t couple cleanly.” The market pays attention to this feedback, which drives demand for the precise 3-bromo, 2-fluoro configuration.
Every lab tech learns quickly that some chemicals ask for extra care. With 3-Bromo-2-Fluoroaniline, that phrase means watching out for dust, inhalation risks, and direct contact. While it doesn’t rate highest on the toxicity scale, its structure—a halogenated aromatic amine—keeps safety officers vigilant. Proper ventilation, gloves, and fume hoods never get skipped. More interesting is the sourcing side: chemical buyers and purchasing agents chase consistent quality and reliable supply lines, especially when deadlines loom. The difference between a smooth pilot batch and a scrapped synthesis can narrow down to shipping delays or a bottle arriving with a certificate of analysis that doesn’t match the fine print needed. Having seen seasoned procurement veterans navigate these mines, I’ve learned the human element matters as much as the molecule itself.
Sustainability and environmental impact often come up during industry interviews. Most synthetic intermediates like 3-Bromo-2-Fluoroaniline are not made on a massive scale, but even specialty production draws scrutiny. Halogenated aromatics linger in the environment and can challenge conventional wastewater treatments, making spill prevention and conscientious disposal crucial. On the plus side, running efficient syntheses that cut down on waste and minimize solvent use does more than lower costs—it keeps regulators and green chemistry advocates out of your hair. A few manufacturers in Europe and East Asia now pitch cleaner routes, using catalytic processes or recyclable reagents, based on both legislation and customer demand. My own observations in the field have shown a gradual shift: eco-friendly certifications matter, but so does old-fashioned reliability. Blending the two makes for supply chains both robust and responsible.
Academic articles often highlight 3-Bromo-2-Fluoroaniline as a test case in the development of new catalytic protocols. Its structure offers an inviting platform to showcase selectivity in functional group transformations. Catalyst designers use it to measure efficacy—the bromine acts as a site for C–C or C–N coupling, while the ortho-fluorine impacts both steric and electronic influences, shaping reaction rates and pathways. Medicinal chemists exploit these effects when they tweak lead compounds, chasing everything from oral bioavailability to improved resistance against enzymatic breakdown. For example, once a synthetic lead includes a 3-Bromo-2-Fluoroaniline scaffold, further modifications explore adding ethers, alkynes, or heterocycles via coupling at the 3-position. In those moments—on the frontier of process chemistry and applied biology—you see how theory becomes practice through a single, thoughtfully designed building block.
In the past, a chemist might buy intermediates from whoever offered the best price or fastest ship time. Expectations are higher now. Traceability, full documentation, and a visible chain of custody for each batch of 3-Bromo-2-Fluoroaniline underpin trust between supplier and researcher. This extends beyond the comfort of seeing an up-to-date certificate of analysis: it’s about knowing that the analytical data have backing from validated methods, that the source batches aren’t mixed or cut, and that the supplier responds quickly to any sign of trouble. For companies counting on data for regulatory filings—or researchers publishing new routes in peer-reviewed journals—this level of documentation makes or breaks collaborations. Conversations I have with lab heads and sourcing officers always track back to verification: “Show me the lot analysis, prove your NMR spectra, let’s see the HPLC trace.” That demand for rigor builds the reputation of both supplier and user communities alike.
The leap from academic curiosity to viable industrial intermediate often runs into speed bumps. Some facilities struggle with the additional handling requirements or run up against limitations in existing reactor setups. Others pivot easily, particularly when the incentive—a more efficient route to a marketable product—outweighs the learning curve. I’ve watched process chemists run pilot trials, dialing in reaction conditions over and over with a sharp eye on yield and safety. What seems like a small molecule on paper represents major investments in equipment, staff training, and process controls. The edge for 3-Bromo-2-Fluoroaniline comes from its role in opening synthetic shortcuts: steps drop, waste shrinks, and the product portfolio grows. This sort of incremental gain adds up, which explains why progressive firms keep a close watch on emerging intermediates in the literature.
Many assume intermediates only matter in the lab, yet their ripple effects extend much further. For 3-Bromo-2-Fluoroaniline, advances in pharmaceutical chemistry can mean more effective painkillers or antibiotics with fewer side effects. In agriculture, novel compounds crafted from this building block may help safeguard yields without contributing as much to environmental load or the development of pest resistance. The dye industry isn’t left out: the compound’s influence on chromophore development can tweak not just the color of fabrics but the fastness and resistance to fading. I recall project stakeholders—chemists, business leads, and marketing teams alike—pouring over emerging data on lead formulations, eager to capture not just market share but also a technical edge. Behind every winning formulation stands a chain of well-chosen intermediates, sometimes built on the back of the exact molecular scaffold 3-Bromo-2-Fluoroaniline provides.
No discussion lands complete without touching on market obstacles. Costs for 3-Bromo-2-Fluoroaniline trace back to raw materials, labor, and the need for specialized containment. Tightening trade regulations and shifting environmental standards push prices up in volatile ways. For chemists working on a shoestring budget, this can lead either to a hard stop or hard compromise—a change in route, a shift in strategy, or a phone call seeking grants. Scale helps: large buyers can often lock prices or build long-term relationships with suppliers for better terms. Others turn to custom synthesis; the catch sits in lead times and minimum order sizes. I’ve seen smaller labs band together or tap cooperative purchasing agreements to circumvent hurdles, turning procurement into a team sport rather than a solitary race.
Trustworthy supply chains, green chemistry, regulatory transparency—these buzzwords gain real weight in the synthesis and sale of 3-Bromo-2-Fluoroaniline. Those who push for ethical sourcing know the score: hazardous byproducts, poorly tracked shipments, and spotty documentation undermine credibility. Research groups committed to open data, sustainable practices, and staff safety gravitate toward sources that put their values up front. The market is shifting, too. I’ve watched younger chemists—those coming out of graduate programs steeped in reproducibility—bring fresh demands on distributors. They want environmental scores, ethics policies, and a say in how waste gets minimized, not just a box on the loading dock. These changes aren’t side notes—they shape which suppliers thrive and which get left behind.
Conversations around 3-Bromo-2-Fluoroaniline often remind me that chemicals succeed as much by their narratives as by their structures. Clear, approachable documentation, straight answers about characteristics and hazards, and the willingness to share practical experience all raise the level of trust. Lab staff and sourcing managers don’t want marketing fluff; they need information that moves their goals forward, cuts risk, and supports better results. This goes right up the chain—from students learning good bench habits to executives signing off on procurement. Being honest about limitations, listening to customer pain points, and committing to expertise become the makings of a responsible marketplace.
3-Bromo-2-Fluoroaniline lands in the hands of a small but influential group: those striving to build new materials, solve urgent biological puzzles, or push forward the limits of functional molecule design. The details—model, precise specification, handling quirks—matter not as trivia, but as the foundation for repeatable, successful outcomes. Recurring conversations with scientists, procurement leaders, and industry veterans reveal the same truth: striking the right balance between innovation, reliability, and responsibility gives this compound a standing that outpaces mere inventory lists. For those building solutions molecule by molecule, paying careful attention to where each building block comes from, how it behaves, and where it can lead may decide not just the success of another synthesis, but the impact those solutions carry into the world beyond the bench.
